Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 75Neoplasms 61Colorectal Neoplasms 41Prostatic Neoplasms 36Carcinoma, Non-Small-Cell Lung 36Lung Neoplasms 30Multiple Myeloma 23Leukemia, Myeloid, Acute 23Head and Neck Neoplasms 18Squamous Cell Carcinoma of Head and Neck 15Neoplasm Metastasis 15Melanoma 15Stomach Neoplasms 14Pancreatic Neoplasms 14Carcinoma, Hepatocellular 14Recurrence 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Ovarian Neoplasms 13Lymphoma, Non-Hodgkin 12Esophageal Neoplasms 10Carcinoma, Renal Cell 10Brain Neoplasms 10Uterine Cervical Neoplasms 9Rectal Neoplasms 9Motor Activity 9Lymphoma 9Colonic Neoplasms 9Myelodysplastic Syndromes 8Leukemia 8Glioma 8

Interventions

itacitinib 1INCB039110 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × B-cell Malignancies × 30 days × Clear all
NCT01905813 2026-05-11

Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies

Incyte Corporation

Phase 1 Completed
121 enrolled
Lymphoid

B-cell Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡